Universe Pharmaceuticals INC (NASDAQ:UPC)’s traded shares stood at 1.58 million during the latest session, with the company’s beta value hitting 1.59. At the last check today, the stock’s price was $0.09, to imply a decrease of -11.02% or -$0.01 in intraday trading. The UPC share’s 52-week high remains $64.80, putting it -71900.0% down since that peak but still an impressive 0.0% since price per share fell to its 52-week low of $0.09. The company has a valuation of $0.76M, with an average of 1.2 million shares in intraday trading volume over the past 10 days and average of 12.36 million shares over the past 3 months.

Universe Pharmaceuticals INC (NASDAQ:UPC) trade information

After registering a -11.02% downside in the latest session, Universe Pharmaceuticals INC (UPC) has traded red over the past five days. The 5-day price performance for the stock is -27.81%, and -41.63% over 30 days. With these gigs, the year-to-date price performance is -85.70%. Short interest in Universe Pharmaceuticals INC (NASDAQ:UPC) saw shorts transact 55577.0 shares and set a 0.0 days time to cover.

UPC Dividends

Universe Pharmaceuticals INC has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Universe Pharmaceuticals INC (NASDAQ:UPC)’s Major holders

Universe Pharmaceuticals INC insiders hold 0.91% of total outstanding shares, with institutional holders owning 3.70% of the shares at 3.74% float percentage. In total, 3.70% institutions holds shares in the company.

Going by data provided on Sep 30, 2024 , Fidelity NASDAQ Composite Index Fund holds roughly 98.0 shares. This is just over 0.00% of the total shares, with a market valuation of $8.0